preclinical research

Good Laboratory Practices Drug discovery

Good Laboratory Practices (GLP) in Preclinical Research: Principles, Compliance, and Impact on Drug Safety

Good Laboratory Practices (GLP) ensure reliable preclinical research, meet FDA standards, and strengthen data integrity in drug development.

Genetics CNS Drug discovery

Fast Gene Target Validation & Drug Screening All In One

Harness the potential of our new Zebrafish-Based Platform for High-Throughput Gene Target Validation and Drug Screening in F0

Genetics

CRISPR Knockouts vs Knockins

The use of target gene-editing in preclinical research

Genetics

Prime editing, a step beyond CRISPR

The most precise CRISPR to date turns the genetic scissors into a Swiss army knife 

Drug discovery

The future of animal testing 

The United States approves technological alternatives to reduce animal testing

CRISPR-the-genetic-scissors Genetics

CRISPR Cas9: The Genetic Scissors

What is CRISPR technology and how can change our lives?

In-vivo-epilepsy-research Drug discovery CNS

Fishing for innovative alternatives for modeling epilepsy

Why zebrafish can pave the way for investigating epilepsy’s etiology and screening new anti-seizure drugs

differences-between-in-vitro-in-vivo-in-silico assays- Drug discovery

Differences between in vitro, in vivo and in silico assays in preclinical research

How to choose which type of experiment is best-suited for my research?

Drug discovery Ophthalmology

Zebrafish on the Move Towards Eye Disorders Research

Leveraging zebrafish to study Age-related Macular Degeneration

Metabolics Drug discovery

Tackling a pandemic with Zebrafish: Obesity and Non-Alcoholic Liver Disease

The emerging use of zebrafish to model metabolic diseases

Zebrafish model organism Drug discovery

Zebrafish as a Translatable Model System

Are zebrafish suitable for human drug discovery?

zebrafish-pharmacologial-disease-model CNS Drug discovery

What can you Learn from a Neuro-Pharmacological Disease Model?

Zebrafish represents a key tool to boost drug discovery by enabling phenotypic screening approach in pharmacological-based disease models.